Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker.
Liu S, Hawley SJ, Kunder CA, Hsu EC, Shen M, Westphalen L, Auman H, Newcomb LF, Lin DW, Nelson PS, Feng Z, Tretiakova MS, True LD, Vakar-Lopez F, Carroll PR, Simko J, Gleave ME, Troyer DA, McKenney JK, Brooks JD, Liss MA, Stoyanova T. Liu S, et al. Among authors: tretiakova ms. Sci Rep. 2024 Jan 4;14(1):486. doi: 10.1038/s41598-023-50215-z. Sci Rep. 2024. PMID: 38177207 Free PMC article.
Sarcomatoid Urothelial Carcinoma Is Associated With Limited Response to Neoadjuvant Chemotherapy and Poor Oncologic Outcomes After Radical Cystectomy.
Sekar RR, Diamantopoulos LN, Bakaloudi DR, Khaki AR, Grivas P, Winters BR, Vakar-Lopez F, Tretiakova MS, Psutka SP, Holt SK, Gore JL, Lin DW, Schade GR, Hsieh AC, Lee JK, Yezefski T, Schweizer MT, Cheng HH, Yu EY, True LD, Montgomery RB, Wright JL. Sekar RR, et al. Among authors: tretiakova ms. Clin Genitourin Cancer. 2023 Aug;21(4):507.e1-507.e14. doi: 10.1016/j.clgc.2023.03.015. Epub 2023 Apr 4. Clin Genitourin Cancer. 2023. PMID: 37150667 Free PMC article.
Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study.
Patel P, Harmon S, Iseman R, Ludkowski O, Auman H, Hawley S, Newcomb LF, Lin DW, Nelson PS, Feng Z, Boyer HD, Tretiakova MS, True LD, Vakar-Lopez F, Carroll PR, Cooperberg MR, Chan E, Simko J, Fazli L, Gleave M, Hurtado-Coll A, Thompson IM, Troyer D, McKenney JK, Wei W, Choyke PL, Bratslavsky G, Turkbey B, Siemens DR, Squire J, Peng YP, Brooks JD, Jamaspishvili T. Patel P, et al. Among authors: tretiakova ms. Mod Pathol. 2023 Oct;36(10):100241. doi: 10.1016/j.modpat.2023.100241. Epub 2023 Jun 19. Mod Pathol. 2023. PMID: 37343766
Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer.
Newcomb LF, Schenk JM, Zheng Y, Liu M, Zhu K, Brooks JD, Carroll PR, Dash A, de la Calle CM, Ellis WJ, Filson CP, Gleave ME, Liss MA, Martin F, McKenney JK, Morgan TM, Tretiakova MS, Wagner AA, Nelson PS, Lin DW. Newcomb LF, et al. Among authors: tretiakova ms. JAMA. 2024 May 30:e246695. doi: 10.1001/jama.2024.6695. Online ahead of print. JAMA. 2024. PMID: 38814624
Molecular Characterization of Juxtaglomerular Cell Tumors: Evidence of Alterations in MAPK-RAS Pathway.
Lobo J, Canete-Portillo S, Pena MDCR, McKenney JK, Aron M, Massicano F, Wilk BM, Gajapathy M, Brown DM, Baydar DE, Matoso A, Rioux-Leclerq N, Pan CC, Tretiakova MS, Trpkov K, Williamson SR, Rais-Bahrami S, Mackinnon AC, Harada S, Worthey EA, Magi-Galluzzi C. Lobo J, et al. Among authors: tretiakova ms. Mod Pathol. 2024 Apr 16;37(6):100492. doi: 10.1016/j.modpat.2024.100492. Online ahead of print. Mod Pathol. 2024. PMID: 38614322
Immunohistochemical Detection of 5T4 in Renal Cell Carcinoma.
Miller CP, Shokri F, Akilesh S, Xu Y, Warren EH, Tykodi SS, Tretiakova M. Miller CP, et al. Appl Immunohistochem Mol Morphol. 2023 Mar 1;31(3):135-144. doi: 10.1097/PAI.0000000000001101. Epub 2023 Feb 6. Appl Immunohistochem Mol Morphol. 2023. PMID: 36735485
Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage.
Nguyen JK, Harik LR, Klein EA, Li J, Corrigan D, Liu S, Chan E, Hawley S, Auman H, Newcomb LF, Carroll PR, Cooperberg MR, Filson CP, Simko JP, Nelson PS, Tretiakova MS, Troyer D, True LD, Vakar-Lopez F, Weight CJ, Lin DW, Brooks JD, McKenney JK. Nguyen JK, et al. Among authors: tretiakova ms. Histopathology. 2024 Jun 3. doi: 10.1111/his.15231. Online ahead of print. Histopathology. 2024. PMID: 38828674
Comprehensive assessment of anaplastic lymphoma kinase in localized and metastatic prostate cancer reveals targetable alterations.
Patel RA, Coleman I, Roudier MP, Konnick EQ, Hanratty B, Dumpit R, Lucas JM, Ang LS, Low JY, Tretiakova MS, Ha G, Lee JK, True LD, De Marzo AM, Nelson PS, Morrissey C, Pritchard CC, Haffner MC. Patel RA, et al. Among authors: tretiakova ms. Cancer Res Commun. 2022 May;2(5):277-285. doi: 10.1158/2767-9764.crc-21-0156. Epub 2022 May 2. Cancer Res Commun. 2022. PMID: 36337169 Free PMC article.
Characterization of Intercalated Cell Markers KIT and LINC01187 in Chromophobe Renal Cell Carcinoma and Other Renal Neoplasms.
Mannan R, Wang X, Bawa PS, Zhang Y, Skala SL, Chinnaiyan AK, Dagar A, Wang L, Zelenka-Wang SB, McMurry LM, Daniel N, Cao X, Sangoi AR, Gupta S, Vaishampayan UN, Hafez KS, Morgan TM, Spratt DE, Tretiakova MS, Argani P, Chinnaiyan AM, Dhanasekaran SM, Mehra R. Mannan R, et al. Among authors: tretiakova ms. Int J Surg Pathol. 2023 Sep;31(6):1027-1040. doi: 10.1177/10668969221125793. Epub 2022 Oct 16. Int J Surg Pathol. 2023. PMID: 36250542
94 results